Tags

Type your tag names separated by a space and hit enter

Antimicrobial resistance trends in Shigella serogroups isolated in Israel, 1990-1995.
Eur J Clin Microbiol Infect Dis 2000; 19(2):108-11EJ

Abstract

From a total of 31319 Shigella strains isolated in Israel between 1990 and 1996, 17574 were sent to the National Shigella Reference Center for typing. Of these, 15287 were identified as Shigella sonnei, 1833 as Shigella flexneri, 327 as Shigella boydii and 127 as Shigella dysenteriae. In all, 4395 strains were tested for sensitivity to ampicillin, trimethoprim-sulfamethoxazole, tetracycline, chloramphenicol, nalidixic acid and ofloxacin. All strains tested were sensitive to ofloxacin, and only three strains were resistant to nalidixic acid. Only 113 of 3240 (3.5%) Shigella sonnei strains, 172 of 970 (17.7%) Shigella flexneri strains and 45 of 185 (24.3%) Shigella boydii strains tested were sensitive to four other antibiotic agents. The rates of resistance of Shigella sonnei, Shigella flexneri and Shigella boydii to trimethoprimsulfamethoxazole were 94.4%, 51.3% and 61.6%, respectively. Rates of resistance to ampicillin among these species were 73.4%, 63.5% and 21.4%, respectively. The proportion of strains exhibiting multiple drug resistance was higher for Shigella sonnei than for the other serotypes studied. These results emphasize the need to reassess the use of antibiotic agents in the treatment of shigellosis.

Authors+Show Affiliations

Department of Laboratories, Ministry of Health, Jerusalem, Israel. lbdabraham@matat.health.gov.ilNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

10746496

Citation

Mates, A, et al. "Antimicrobial Resistance Trends in Shigella Serogroups Isolated in Israel, 1990-1995." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, vol. 19, no. 2, 2000, pp. 108-11.
Mates A, Eyny D, Philo S. Antimicrobial resistance trends in Shigella serogroups isolated in Israel, 1990-1995. Eur J Clin Microbiol Infect Dis. 2000;19(2):108-11.
Mates, A., Eyny, D., & Philo, S. (2000). Antimicrobial resistance trends in Shigella serogroups isolated in Israel, 1990-1995. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, 19(2), pp. 108-11.
Mates A, Eyny D, Philo S. Antimicrobial Resistance Trends in Shigella Serogroups Isolated in Israel, 1990-1995. Eur J Clin Microbiol Infect Dis. 2000;19(2):108-11. PubMed PMID: 10746496.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Antimicrobial resistance trends in Shigella serogroups isolated in Israel, 1990-1995. AU - Mates,A, AU - Eyny,D, AU - Philo,S, PY - 2000/4/4/pubmed PY - 2000/6/17/medline PY - 2000/4/4/entrez SP - 108 EP - 11 JF - European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology JO - Eur. J. Clin. Microbiol. Infect. Dis. VL - 19 IS - 2 N2 - From a total of 31319 Shigella strains isolated in Israel between 1990 and 1996, 17574 were sent to the National Shigella Reference Center for typing. Of these, 15287 were identified as Shigella sonnei, 1833 as Shigella flexneri, 327 as Shigella boydii and 127 as Shigella dysenteriae. In all, 4395 strains were tested for sensitivity to ampicillin, trimethoprim-sulfamethoxazole, tetracycline, chloramphenicol, nalidixic acid and ofloxacin. All strains tested were sensitive to ofloxacin, and only three strains were resistant to nalidixic acid. Only 113 of 3240 (3.5%) Shigella sonnei strains, 172 of 970 (17.7%) Shigella flexneri strains and 45 of 185 (24.3%) Shigella boydii strains tested were sensitive to four other antibiotic agents. The rates of resistance of Shigella sonnei, Shigella flexneri and Shigella boydii to trimethoprimsulfamethoxazole were 94.4%, 51.3% and 61.6%, respectively. Rates of resistance to ampicillin among these species were 73.4%, 63.5% and 21.4%, respectively. The proportion of strains exhibiting multiple drug resistance was higher for Shigella sonnei than for the other serotypes studied. These results emphasize the need to reassess the use of antibiotic agents in the treatment of shigellosis. SN - 0934-9723 UR - https://www.unboundmedicine.com/medline/citation/10746496/Antimicrobial_resistance_trends_in_Shigella_serogroups_isolated_in_Israel_1990_1995_ L2 - https://dx.doi.org/10.1007/s100960050439 DB - PRIME DP - Unbound Medicine ER -